Clinical Trial Update: 68Ga-PSMA PET/CT for Ra223 Assessment [NA]

View source ↗

Summary

A clinical trial at Chang Gung Memorial Hospital is recruiting to assess 68Ga-PSMA PET/CT imaging for evaluating Radium-223 therapy in metastatic prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Gallium-68 PSMA imaging agent (gallium-68 PSMA)
• Radium-223 dichloride (radium-223 dichloride)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Metastatic Prostate Cancer | NA | Status: RECRUITING